[1]
Ali, R. et al. 2025. COMPARISON OF SOLIFENACIN VERSUS MIRABEGRON IN WOMEN WITH OVERACTIVE BLADDER PRESENTING AT A TERTIARY CARE HOSPITAL. Insights – Journal of Health and Rehabilitation. 3, 6 (Jun. 2025), 974–980. DOI:https://doi.org/10.71000/w0kqhw21.